Neoadjuvant chemotherapy and primary‐first approach for rectal cancer with synchronous liver metastases
Colorectal Disease2013Vol. 16(6), pp. O197–205
Citations Over Time
Tamara Gall, Mohamed Basyouny, Adam E. Frampton, Ara Darzi, Paul Ziprin, Peter Dawson, P. Paraskeva, Nagy Habib, Duncan Spalding, Susan Cleator, C. Lowdell, Long R. Jiao
Abstract
Rectal resection before hepatic resection combined with neoadjuvant chemotherapy is associated with promising clinical outcome. It allows downstaging of liver lesions and removal of the primary tumour before the progression of further micrometastases. Furthermore, patients who do not respond to chemotherapy can be identified and may avoid major surgical intervention.
Related Papers
- → Fichandler Stage, Arena Stage(2004)
- → Clinicopathological Study of Endemic Goiter(1978)
- Expression of PTTG and its significance in colorectal cancer(2008)
- → NEW CRITERIA FOR BLADDER TUMOR STAGING BY COMPUTED TOMOGRAPHY(1981)
- → 3. Stage Directions and Stage Properties(1971)